北大医药
(000788)
| 流通市值：43.86亿 | | | 总市值：43.86亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 659,874,162.64 | 607,031,439.52 | 546,908,115.95 | 617,331,063.68 |
| 交易性金融资产 | 29,165,422.04 | - | - | - |
| 应收票据及应收账款 | 780,001,267.32 | 1,071,178,974.9 | 1,121,606,959.26 | 1,022,878,702.94 |
| 其中：应收票据 | 23,420,723.93 | 22,038,326.15 | 25,160,029.95 | 25,342,712.19 |
| 应收账款 | 756,580,543.39 | 1,049,140,648.75 | 1,096,446,929.31 | 997,535,990.75 |
| 应收款项融资 | 59,686,128.06 | 60,532,332.84 | 45,024,933.71 | 36,625,301.05 |
| 预付款项 | 14,592,122.83 | 10,178,780.73 | 17,088,156.58 | 15,066,010.7 |
| 其他应收款合计 | 64,337,013.03 | 62,518,415.13 | 63,597,538.17 | 62,628,606.99 |
| 存货 | 144,050,213.88 | 166,722,683.29 | 190,808,003.61 | 188,893,796.33 |
| 一年内到期的非流动资产 | - | 652,218.63 | - | 736,103.66 |
| 其他流动资产 | 4,472,847.94 | - | - | - |
| 流动资产合计 | 1,756,179,177.74 | 1,978,814,845.04 | 1,985,033,707.28 | 1,944,159,585.35 |
| 非流动资产: | | | | |
| 长期应收款 | - | 1,810,223.95 | 2,389,468.49 | 2,608,390.74 |
| 投资性房地产 | 14,703,216.67 | 15,029,954.83 | 15,356,692.99 | 15,683,431.15 |
| 固定资产 | 118,074,054.76 | 116,224,617.83 | 119,643,803.18 | 121,532,693.36 |
| 在建工程 | 162,131.86 | - | - | 320,000 |
| 使用权资产 | 20,148,932.88 | 23,064,103.51 | 25,489,648.37 | 30,737,185.43 |
| 无形资产 | 124,460,077.59 | 123,359,113.34 | 127,322,399.63 | 131,376,976.4 |
| 开发支出 | 20,571,442.52 | 20,346,975.72 | 17,112,323.26 | 14,879,882.47 |
| 递延所得税资产 | 7,115,391.65 | 9,099,918.94 | 10,066,914.89 | 11,370,126.39 |
| 其他非流动资产 | 37,475,536.45 | 32,996,287.77 | 17,841,503.32 | 17,855,872.33 |
| 非流动资产合计 | 342,710,784.38 | 341,931,195.89 | 335,222,754.13 | 346,364,558.27 |
| 资产总计 | 2,098,889,962.12 | 2,320,746,040.93 | 2,320,256,461.41 | 2,290,524,143.62 |
| 流动负债: | | | | |
| 短期借款 | 30,025,833.31 | 30,025,833.32 | 30,028,416.66 | 30,028,416.67 |
| 应付票据及应付账款 | 272,452,502.32 | 496,998,026.71 | 505,416,793.63 | 471,189,231.86 |
| 其中：应付票据 | 70,274,408.5 | 68,705,207 | 42,007,225.55 | 42,316,751.03 |
| 应付账款 | 202,178,093.82 | 428,292,819.71 | 463,409,568.08 | 428,872,480.83 |
| 合同负债 | 4,843,373.48 | 5,492,776.3 | 10,998,786.96 | 13,677,126.32 |
| 应付职工薪酬 | 23,276,283.74 | 24,163,442.43 | 19,136,363.93 | 43,256,827.13 |
| 应交税费 | 12,653,625.28 | 10,100,097.3 | 10,169,589.72 | 13,613,814.25 |
| 其他应付款合计 | 105,710,483.57 | 115,263,644.51 | 138,449,094.21 | 152,211,099.18 |
| 应付股利 | 6,084,284.99 | - | - | - |
| 一年内到期的非流动负债 | 13,277,888.19 | 15,972,304.52 | 18,744,881.58 | 22,830,533.22 |
| 其他流动负债 | 627,938.57 | 714,060.93 | 1,429,842.32 | 1,404,362.73 |
| 流动负债合计 | 462,867,928.46 | 698,730,186.02 | 734,373,769.01 | 748,211,411.36 |
| 非流动负债: | | | | |
| 租赁负债 | 4,860,776.12 | 8,103,461.45 | 8,185,777.98 | 10,769,985.89 |
| 递延收益 | 16,831,150.33 | 17,389,407.49 | 17,947,664.65 | 17,434,046.81 |
| 非流动负债合计 | 21,691,926.45 | 25,492,868.94 | 26,133,442.63 | 28,204,032.7 |
| 负债合计 | 484,559,854.91 | 724,223,054.96 | 760,507,211.64 | 776,415,444.06 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 595,987,425 | 595,987,425 | 595,987,425 | 595,987,425 |
| 资本公积 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 | 199,172,934.88 |
| 盈余公积 | 69,580,677.47 | 69,580,677.47 | 62,537,482.28 | 62,537,482.28 |
| 未分配利润 | 750,235,452.98 | 732,428,331.74 | 702,697,790.73 | 657,057,240.52 |
| 归属于母公司股东权益合计 | 1,614,976,490.33 | 1,597,169,369.09 | 1,560,395,632.89 | 1,514,755,082.68 |
| 少数股东权益 | -646,383.12 | -646,383.12 | -646,383.12 | -646,383.12 |
| 股东权益合计 | 1,614,330,107.21 | 1,596,522,985.97 | 1,559,749,249.77 | 1,514,108,699.56 |
| 负债和股东权益合计 | 2,098,889,962.12 | 2,320,746,040.93 | 2,320,256,461.41 | 2,290,524,143.62 |
| 公告日期 | 2025-10-31 | 2025-08-22 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |